1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam.

Slides:



Advertisements
Similar presentations
Rational Drug Use Supported by USAID Prescribing, Dispensing, Counseling and Adherence in ART Programs.
Advertisements

M ANAGING ARV REGIMEN FAILURE IN THE HIV INFECTED CHILD Dr L Keet Centre of Excellence HIV Directorate.
High rates of survival, virologic suppression and immune reconstitution among patients receiving second-line ART in the Indian national programme B.B.
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 20th, 2014 Evidence.
6/28/00TPED1 Resistance Testing: What is it? What does it mean? How does drug resistance emerge? Overview of methods Advantages and disadvantages Current.
Salvage Antiretroviral Therapy Guiding Principles, Strategies and the Role of Resistance Testing.
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Session Three: Links between Nutrition and HIV. 2 Purpose Provide information about the relationship between nutrition and HIV.
Module 6: Treatment options. Module goal To enable participants understand the best current treatment options, factors that influence outcomes and potential.
Am I affected by AIDS?.
2 About HIV: Teaching Tool. About HIV: A teaching tool © 2nd edition 2006 This tool was developed by the François-Xavier Bagnoud Center at the University.
KITSO AIDS Training Program
Validating five questions of antiretroviral non-adherence in a decentralized public-sector antiretroviral treatment program in rural South Africa Krisda.
Introduction to ARV therapy
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
1 Lecture 9: Adherence in ARV Therapy delivered by Dr. Ndwapi Ndwapi, BHP KITSO AIDS Training Program.
ARV Nurse Training, Africaid, 2004 ARV Nurse Training Programme Marcus McGilvray & Nicola Willis About Resistance.
HIV Organ Policy Equity (HOPE) Act Research Criteria: follow-up discussion Advisory Committee on Organ Transplantation April 13, 2015.
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 First Clinic Visit for Patients with HIV Infection HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Office of Overseas Programming & Training Support (OPATS) Overview of Care, Support, and Treatment HIV Care, Support, and Treatment.
Clinical Care of HIV, AIDS and Opportunistic Infections
Nurses SOAR! Training Curricula Series For More Information and Inquiries:
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
1 Review of Antiretroviral Therapy in Adults HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV-1 Resistance - Implications For Clinicians Joseph J. Eron Jr., MD Professor of Medicine University of North Carolina.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
BHIVA Clinical Audit Management of patients who switch therapy; re-audit of patients starting therapy from naïve.
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
1 ARV Drug Resistance HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Monitoring The Patient on ARV Treatment HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Introduction to ARV Therapy HAIVN Harvard Medical School AIDS Initiative in Vietnam.
M. Ekstrand 1,2,3, A. Shet 2,4, S. Chandy 4, G. Singh 4, R. Shamsundar 4, V. Madhavan 5, S. Saravanan 5, N. Kumarasamy 5 1 University of California, San.
Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.
11 NAPWA Symposium 6 th IAS Meeting An HIV-based Lentiviral Vector Vaccine Achieves Functional Cure Post-challenge in a Subset of Vaccinated Macaques Dr.
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Clinical case 19 Lin, I-Yao (Sally). Case 19 Having been confined in the hospital for almost a month due recurrent pneumonia, Mr. XXX, 42 y/o, married,
P1 Virology, Pathogenesis And Treatment Of HIV Infection.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
Blood Tests (“Labs”) 1. “Labs” Regular blood tests are a crucial part of HIV health care. They are often referred to as “bloods” or “labs” Several important.
Drug Adherence and Strategies for Compliance Assist. Prof. Dr. Memet IŞIK Ataturk University Medical Faculty Department of Family Medicine
HAIVN Harvard Medical School AIDS Initiative in Vietnam
1 Pediatric ARV adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Strategies for Management of Antiretroviral Therapy Study Wafaa El-Sadr and James Neaton for the SMART Study Team.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HAIVN Harvard Medical School AIDS Initiative in Vietnam
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Major Changes to the HHS Adult and Adolescent HIV Treatment Guidelines: April 2015 Brian R. Wood, MD.
Virology – Antivirals 2 JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University. MBBS (J.U.S.T)
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 94 Antiviral Agents II: Drugs for HIV Infection and.
POSITIVE PREVENTION YOUNG PEOPLE’S TRAINING BY; HADIA HAWA.
First-Line Treatment of HIV Infection With Either NNRTI- or PI-Based Regimens Effective for Long-term Disease Control Slideset on: MacArthur RD, Novak.
Treatment of HBV/HCV Coinfection
Learning objectives Review HIV treatment goals
Learning objectives Define HIV treatment goals
Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.
Paediatric HIV and Adherence
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Utilizing research as an opportunity to strengthen
VL patient support: General education at different levels
Hiv.
EVALUATION OF ANTIRETROVIRAL THERAPY FOLLOWED BY AN EDUCATIONAL INTERVENTION TO INCREASE APPROPRIATE USE IN ZIMBABWE.
ARV Nurse Training Programme Marcus McGilvray & Nicola Willis
ANTIRETROVIRAL RESISTANCE IN CLINICAL PRACTICE
Presentation transcript:

1 Adherence to ARV Therapy and Resistance HAIVN Havard Medical School AIDS Initiative in Vietnam

2 By the end of this session, participants will be able to: Present the importance of good adherence to ARV therapy List the 5 main reasons leading to non adherence Describe 3 types of adherence Explain the relationship between adherence and drug resistance Learning Objectives

3 Adherence

4 Adherence means taking right drugs, in proper dose and on time To achieve the best effect with ARV therapy, adherence rate is required to be above 95% Example: If medications are prescribed 2 times a day, don’t forget more than 2 doses a month. Definition

Common types of adherence Howard AIDS 2002; Ickovics Antiviral Ther 2002; Moss CID 2004 Adherence Treatment time (month) 100% 0% Three types of patient’s adherence Very good adherence Reduced adherence Non adherence

6 Any activity: support, or help to improve the health of people with HIV / AIDS pay attention to the care and treatment of people with HIV, including: Physical health status Mental, psychosocial well-being Extended definition of adherence

7 Maximal inhibition of viral load Reduce drug resistance Ensure effect time of drug All above helps: Slow progression of HIV Prolong survival Goals of adherence to ARV drugs

8 Drug resistance

Improve physical health No more opportunistic infections Clinical status CD4 count increases: At least from cells in the first year Increase cells in the second year Immunology* Viral load is undetectable after 12 months Virology Adherence: Definition Adherence : according to Kaufman and Le Moing, WHO

10 Patients who do not improve on clinical immunologic and viral outcome after starting ART therapy are considered not to respond to treatment Non adherence: Definition

11 Resistance leads to the failure of ARV therapy Intolerance with ARV drugs aggravates the disease Drug interactions causes ARV levels below the threshold of viral suppression Non adherence: Causes

Drug level below the threshold of viral suppression Viral replication continues with the presence of drugs DRUG RESISTANCE Drug resistance Drug resistance is often, but not always due to non adherence

How does HIV drug resistance occur? Resistant virus Social/ personal issues Regimen issue Toxicity Poor quality drugs Wrong dose Host genetics Poor absorption Rapid clearance Poor activation Drug interaction Transmission Poor adherence Insufficient drug level Viral replication in the presence of drug

14 HIV has an extremely high rate of replication The new generation of virus is little different from the previous generation Some structural changes can improve the ability of viral replication When virus can multiply in the presence of ARV drugs, it can be said that virus is resistant to drugs How does HIV develop resistance?

15 Level of drugs below the threshold of treatment Wild-type virus Resistant virus Effect of non adherence to the development of viral mutations

The relationship between the level of adherence and the risk of drug resistance Williams & Fiedland, 1997 Risk of drug resistance % Adherence 0100

17 Some comments: 50% of people living with HIV (not taking into account the current status of treatment) there is evidence for at least one drug resistance 78% of people who have HIV treatment are resistant to at least one antiviral drug Resistant HIV CROSS-RESISTANCE: Resistance to a drug in a group often leads to resistance to another drug in that group!

18 Drug resistant HIV can transmit: to new HIV infections as well as to co-infections Risk of transmission

19 ARV therapy failure is often, but not always, due to drug resistance Failure of ARV therapy is expressed by: Increased viral load Reduced CD4 count + T cells Progression to AIDS ARV therapy failure

20 Good adherence will reduce the risk of the development of ARV resistance Drug resistance is a major problem For individuals For society Why is adherence mentioned?

21 Good adherence to ARV therapy is necessary but very difficult Non adherence results in low drug concentration in the blood and allows the development of drug resistant HIV ARV resistance leads to treatment failure Transmission of drug-resistant virus from one person to another occurs and is a public health problem Key points

22 Thank you Question?